The Multicentre pilot study of the effet of pravastatin treatment on high molecular weight adiponectin blood concentration in patients with dyslipidemia -Kanazawa, Yokohama-

The Multicentre pilot study of the effet of pravastatin treatment on high molecular weight adiponectin blood concentration in patients with dyslipidemia -Kanazawa, Yokohama- - Dyslipidemia Open labeled pilot study by lipid lowering therapy with Pravastatin to elucidate the effect to increase High-molecular weight adiponectin by investigators in Nippon Yokohama(DOLPHIN)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000000791

Enrollment

Registered

2007-08-08

Start date

2007-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyslipidemia

Interventions

Patients will receive pravastatin 5-10mg/day for 6 months.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed as dyslipidemia(LDL-C>140mg/dL) 2. Outpatient clinic patients in Kanazawa ward 3. Patients who fall into category 2 or 3 of Japan Atherosclerosis Society(JAS) Guidelines for diagnosis and prevention of atherosclerotic cardiovascular disease for Japanese 4. Informed concent on the form filled out by the patient.

Exclusion criteria

Exclusion criteria: 1. Familial hyperlipidemia 2. Ischemic heart disease 3. Patients who is already taking statin

Design outcomes

Primary

Measure	Time frame
The change of serum high-molecular weight adiponectin concentration	—

Secondary

Measure	Time frame
1.The alteration in glucose metabolism 2.The change in serum lipid levels 3.The change in serum hs-CRP 4.The change in serum total adiponectin concentration	—

Countries

Japan

Contacts

Public ContactUru Nezu

Yokohama City University Graduate School of Medicine Department of Endocrinology & Metabolism

045-787-2639

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026